Hospitals are being asked to hold the line on infection with disinfection that resistant, biofilm-forming pathogens increasingly survive, while every failure carries clinical, financial and regulatory cost.
Healthcare-associated infection already costs the NHS between roughly GBP 774m and GBP 2.1bn a year, adds about GBP 1,457 to the cost of every case, and ties up close to a fifth of bed capacity. Each outbreak is also a reputational and regulatory event.
Antimicrobial resistance is making it worse. More than 1.2 million people already die from resistant infections each year, a figure projected to reach 10 million by 2050, and the pathogens that matter most form biofilms that are around a thousand times more resistant to conventional disinfectants than free-floating cells.
At the same time, statutory water and ventilation standards (HTM 04-01 for Legionella and water safety, HTM 03-01 for ventilation) carry direct CQC enforcement, and the national AMR action plan now holds you to preventing any rise in gram-negative bloodstream infections. The duty is continuous, and the evidence has to be there on inspection.
We target the exact failure mode conventional control struggles with, biofilm and resistant pathogens in your water and air, and leave you with the verified evidence your duties require.
Across water systems, surfaces and indoor air, we deploy disinfection and purification that work against antimicrobial-resistant and biofilm-forming organisms, not just the easy targets. The result is lower bioburden where infection actually starts, with no ozone or harmful byproducts and no toxic residue left in a clinical environment.
It fits the estate and the care you already run. There is no need to take wards, theatres or water systems out of service, and every outcome is independently verified, so the same work that lowers infection risk also produces the HTM and CQC evidence your Water Safety Group and inspectors expect. One accountable partner carries the integration.
Remove up to 99.9% of airborne pathogens in independent testing, with no ozone or harmful byproducts, in the wards, theatres and augmented-care areas where air quality affects clinical outcomes.
Bring waterborne bioload down and keep it down. A recurring pathogen problem was eliminated to 0 cfu/g in four days where conventional dosing had failed for years, confirmed by a UKAS-accredited laboratory.
Target the biofilm where antimicrobial-resistant organisms hide and survive, with independently verified removal of 99.99% of biofilm (ASTM E2799), the exact failure mode conventional disinfection struggles with.
Meet HTM 04-01 and HTM 03-01 duties and the national AMR action plan with independently verified results your Water Safety Group and CQC inspectors can rely on.
Reduce energy and water running cost across a continuously operating estate, and take out the recurring cost of repeat treatment, outbreaks and lost bed-days.
For new-build and international facilities, a proven pathway to JCI accreditation, with environmental and infection-control standards designed in from the start.
Clinically relevant evidence, independently verified.
The first question any infection-control or estates team asks is the right one: show me the clinical evidence, and tell me it will not disrupt care.
So we lead with both. Every outcome is backed by independent, accredited or peer-reviewed evidence, framed for your Water Safety Group and your CQC file. It works around live clinical operations, with no need to take wards, theatres or water systems offline, and it keeps you within HTM 04-01 and HTM 03-01. We start with an infection-risk review of one system or area, prove the result, then extend it across the estate.
Yes. Results are confirmed by UKAS-accredited and water-authority laboratories and supported by peer-reviewed research, including elimination of waterborne pathogens to 0 cfu/g and independently verified removal of 99.99% of biofilm (ASTM E2799).
No. The approach is designed to work around live clinical operations. There is no need to take wards, theatres or water systems out of service while infection risk is reduced.
Yes. It is designed to support your statutory water (HTM 04-01) and ventilation (HTM 03-01) duties, and it produces the independently verified evidence your Water Safety Group and CQC inspection require.
Yes. It targets exactly those organisms. Resistant pathogens survive in biofilm that is around a thousand times more resistant to conventional disinfectants, and independent testing confirms activity against resistant strains and removal of 99.99% of biofilm.
Yes. It removes up to 99.9% of airborne pathogens in independent testing with no ozone or harmful byproducts, so there is no toxic residue in the spaces where patients are treated.
Yes. For new-build and international hospitals there is a proven pathway to JCI accreditation, with environmental and infection-control standards designed in from the start.
Tell us where infection or compliance risk sits hardest in your estate. We will review it and show you the outcome, in confidence, before you commit.
Tell us the cost, the risk or the obligation you are facing. A senior member of our team will respond, in confidence, with how we would help.
